Danaher Corporation (DHR) Financials

DHR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 83.5 billion 30.6 billion
Dec. 31, 2025 83.5 billion 30.9 billion
Sept. 30, 2025 79.9 billion 28.8 billion
June 30, 2025 81.6 billion 29.3 billion

DHR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 1.1 billion 58.0 million
Dec. 31, 2025 1.7 billion 146.0 million
Sept. 30, 2025 1.4 billion 83.0 million
June 30, 2025 1.1 billion 91.0 million

DHR Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 1.0 billion
Dec. 31, 2025 1.2 billion
Sept. 30, 2025 908.0 million
June 30, 2025 555.0 million

DHR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 5.7 billion 17.6 billion -
Dec. 31, 2025 4.6 billion 18.4 billion 1.3 billion
Sept. 30, 2025 1.5 billion 16.8 billion -
June 30, 2025 3.0 billion 16.9 billion -

DHR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 711.2 million
Dec. 31, 2025 711.0 million
Sept. 30, 2025 713.7 million
June 30, 2025 719.1 million

DHR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 237.0 million 387.0 million 1.9 billion -
Dec. 31, 2025 371.0 million 438.0 million 2.0 billion -
Sept. 30, 2025 292.0 million 378.0 million 2.0 billion -
June 30, 2025 248.0 million 403.0 million 2.4 billion -

DHR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 6.0 billion 2.4 billion
Dec. 31, 2025 6.8 billion 2.9 billion
Sept. 30, 2025 6.1 billion 2.5 billion
June 30, 2025 5.9 billion 2.0 billion

DHR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

DHR

List: Contenders

Price: $166.37

52 week price:
160.93
242.80

Dividend Yield: 0.73%

5-year range yield:
0.26%
0.93%

Forward Dividend Yield: 0.80%

Payout Ratio: 19.89%

Payout Ratio Range:
-3.32%
41.26%

Dividend Per Share: 1.60 USD

Earnings Per Share: 5.16 USD

P/E Ratio: 34.35

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 1.8 million

Ebitda: 1.3 billion

Market Capitalization: 140.1 billion

Average Dividend Frequency: 4

Years Paying Dividends: 34

DGR3: 8.80%

DGR5: 11.15%

DGR10: 30.00%

DGR20: 30.00%

Links: